Foundation Medical Partners

Total investments

44

Average round size

18M

Portfolio companies

19

Rounds per year

1.91

Lead investments

3

Follow on index

0.57

Exits

11

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsHospitalManufacturingMedical DeviceMedicalMarketingPharmaceuticalCosmetic Surgery

Summary

Foundation Medical Partners is the famous VC, which was founded in 2001. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Norwalk.

Besides them, we counted 1 critical employee of this fund in our database.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Foundation Medical Partners, startups are often financed by DeNovo Ventures, Sprout Group, Three Arch Partners. The meaningful sponsors for the fund in investment in the same round are Chicago Growth Partners, New Leaf Venture Partners, DeNovo Ventures. In the next rounds fund is usually obtained by DeNovo Ventures, Chicago Growth Partners, Radius Ventures.

The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight EndoGastric Solutions, Direct Flow Medical, Coapt Systems. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical, Medical Device.

Comparing to the other companies, this Foundation Medical Partners performs on 3 percentage points less the average number of lead investments. The increased amount of exits for fund were in 2014. The fund is generally included in 2-6 deals every year. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2009.

Show more

Investments analytics

Analytics

Total investments
44
Lead investments
3
Exits
11
Rounds per year
1.91
Follow on index
0.57
Investments by industry
  • Health Care (38)
  • Medical Device (28)
  • Medical (17)
  • Biotechnology (13)
  • Health Diagnostics (13)
  • Show 12 more
Investments by region
  • United States (44)
Peak activity year
2009

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
46M
Group Appearance index
0.98
Avg. company exit year
10
Avg. multiplicator
0.95

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
IlluminOss Medical 30 Mar 2007 Health Care, Manufacturing, Medical Device, Medical Early Stage Venture 2M United States, Rhode Island, East Providence
Marinus Pharmaceuticals 03 May 2009 Biotechnology, Health Diagnostics, Pharmaceutical Early Stage Venture 20M United States, Connecticut
Valor Connect 01 Mar 2015 Apps, Professional Networking Seed 200K United States, Pennsylvania, Bethlehem

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.